Bronchodilators not routinely recommended for bronchiolitis in infants and children ============================================ ●We suggest not routinely administering inhaled bronchodilators (albuterol or epinephrine) to infants and children with bronchiolitis (Grade 2B) In November 2014, the American Academy of Pediatrics released updated guidelines for the diagnosis, management, and prevention of bronchiolitis . The 2014 guideline recommends against the administration of inhaled albuterol or epinephrine in the treatment of bronchiolitis; the previous guideline (2006) included a trial of bronchodilators as an option. We agree that bronchodilators should not be used routinely in the treatment of bronchiolitis and no longer suggest a trial of bronchodilators. Although bronchodilators may provide modest short-term clinical improvement, they do not affect overall outcome, may have adverse effects, and increase the cost of care. While we no longer routinely suggest inhaled bronchodilators for infants and children with bronchiolitis, a one-time trial of inhaled bronchodilators may be warranted for infants and children with bronchiolitis and severe disease (eg, nasal flaring; retractions; grunting; respiratory rate >70 breaths per minute; dyspnea; or cyanosis) or respiratory failure. ------------------------------------ UpToDate #هشام_سعد_إبراهيم
Posted on: Tue, 27 Jan 2015 06:11:46 +0000
Trending Topics
Recently Viewed Topics
© 2015